Complete financial analysis of G Medical Innovations Holdings Ltd (GMVD) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of G Medical Innovations Holdings Ltd, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Zijin Mining Group Company Limited (601899.SS) Income Statement Analysis – Financial Results
- Regal Rexnord Corporation (RRX) Income Statement Analysis – Financial Results
- Bristol & West plc 8.125% PRF GBP1 (BWSA.L) Income Statement Analysis – Financial Results
- Japan Medical Dynamic Marketing, INC. (JMDMF) Income Statement Analysis – Financial Results
- International Flavors & Fragrances Inc. (IFF) Income Statement Analysis – Financial Results
G Medical Innovations Holdings Ltd (GMVD)
About G Medical Innovations Holdings Ltd
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. The company was incorporated in 2014 and is based in Rehovot, Israel.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|
| Revenue | 4.42M | 5.06M | 4.90M | 5.53M | 3.06M | 109.00K | 0.00 |
| Cost of Revenue | 3.64M | 3.56M | 4.23M | 5.75M | 4.03M | 1.16M | 0.00 |
| Gross Profit | 784.00K | 1.50M | 667.00K | -223.00K | -969.00K | -1.05M | 0.00 |
| Gross Profit Ratio | 17.74% | 29.70% | 13.61% | -4.04% | -31.65% | -959.63% | 0.00% |
| Research & Development | 2.29M | 1.68M | 1.32M | 2.55M | 243.00K | 186.00K | 0.00 |
| General & Administrative | 24.86M | 9.01M | 7.66M | 10.00M | 12.61M | 24.01M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 3.46M | 664.00K | 356.00K | 0.00 |
| SG&A | 24.86M | 9.01M | 7.66M | 10.00M | 13.27M | 24.36M | 0.00 |
| Other Expenses | 1.05M | 854.00K | 3.70M | 0.00 | 2.70M | 0.00 | 0.00 |
| Operating Expenses | 28.19M | 11.54M | 12.67M | 12.56M | 16.22M | 25.48M | 0.00 |
| Cost & Expenses | 31.83M | 15.10M | 16.90M | 18.30M | 28.69M | 26.63M | 0.00 |
| Interest Income | 0.00 | 870.00K | 344.00K | 263.00K | 858.00K | 282.00K | 0.00 |
| Interest Expense | 0.00 | 4.49M | 750.00K | 3.85M | 995.00K | 923.00K | 0.00 |
| Depreciation & Amortization | -10.34M | 1.00M | 3.61M | 2.01M | 2.61M | 176.00K | 22.82K |
| EBITDA | -37.75M | -9.04M | -8.40M | -12.52M | -13.71M | -26.06M | 0.00 |
| EBITDA Ratio | -854.10% | -178.67% | -171.39% | -226.49% | -447.88% | -23,911.01% | 0.00% |
| Operating Income | -27.41M | -10.04M | -12.00M | -14.53M | -16.33M | -26.24M | 0.00 |
| Operating Income Ratio | -620.14% | -198.44% | -244.98% | -262.87% | -533.18% | -24,072.48% | 0.00% |
| Total Other Income/Expenses | 13.47M | -3.62M | -702.00K | -3.58M | -137.00K | -923.00K | 0.00 |
| Income Before Tax | -13.94M | -14.89M | -12.71M | -16.36M | -17.32M | -27.16M | 0.00 |
| Income Before Tax Ratio | -315.43% | -294.40% | -259.31% | -296.11% | -565.68% | -24,919.27% | 0.00% |
| Income Tax Expense | 16.00K | -3.00K | -18.00K | -857.00K | -345.00K | 85.00K | 0.00 |
| Net Income | -13.96M | -14.89M | -12.69M | -15.51M | -16.98M | -27.25M | 0.00 |
| Net Income Ratio | -315.79% | -294.35% | -258.94% | -280.60% | -554.41% | -24,997.25% | 0.00% |
| EPS | 0.00 | -45.89 | -60.40 | -7.00 | -8.60 | -20.39 | 0.00 |
| EPS Diluted | 0.00 | -45.89 | -60.40 | -7.00 | -8.60 | -20.39 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 324.45K | 210.07K | 2.21M | 1.97M | 1.34M | 71.11M |
| Weighted Avg Shares Out (Dil) | 0.00 | 324.45K | 210.07K | 2.21M | 1.97M | 1.34M | 71.11M |
G Medical Innovations Holdings Ltd. Reports Financial Results for the Six Months Ended June 30, 2021, with Revenue up 45.5%
GMVD Stock: Why It Significantly Increased Today
G Medical Innovations: The Next Generation of Healthcare for Caregivers and Patients
SmallCapsDaily: G Medical Innovations is an Ideal Blend of Growth and Profitability
Short Squeeze Stocks: XELA, NEGG and 3 Other Stocks Experts Think Are Ready to Pop
Best Reddit Penny Stocks to Buy Now? 7 for Your July Small-Caps List
Source: https://incomestatements.info
Category: Stock Reports